5/27/2026 10:49:10 AM MHRA consults on draft regulatory framework for rare disease therapies By Bobbie Bickerton Alison Llewellyn On 21 May 2026, the Medicines and Healthcare products Regulatory Agency (“MHRA”) published its draft regulatory framework for rare...
5/21/2026 11:06:07 AM AI Chatbots Facing Tighter Rules Under New Laws By Alison Llewellyn Simon Bollans The UK’s approach to regulating AI chatbots is shifting rapidly in an effort to keep pace with technological change and address the risks...
5/15/2026 1:49:12 PM Competition Law Meets AI: Enforcement Heats Up By Marta Garcia Competition authorities in the EU and the UK are increasingly scrutinising whether AI‑driven products, data tools and digital ecosystems...
5/11/2026 3:12:39 PM EU Digital Omnibus Deal: Simplification of AI Act and Postponed Deadlines By Simon Bollans Katie Hewson Alison Llewellyn On 7 May 2026, the European Parliament and the Council of the European Union reached a provisional political agreement under the European...
5/11/2026 8:02:48 AM Preparing for the FCA’s Non-Financial Misconduct Rules: Lessons from Q1 2026 Whistleblowing Data By Alan Ward Leadership conduct is now the second-largest category for whistleblowing reports received by the Financial Conduct Authority. With the...